Your browser doesn't support javascript.
loading
Sustained effectiveness and safety of subcutaneous tocilizumab over two years in the ARATA observational study.
Behrens, Frank; Burmester, Gerd-Rudiger; Hofmann, Michael W; Aringer, Martin; Kellner, Herbert; Liebhaber, Anke; Wassenberg, Siegfried; Peters, Marvin A; Zortel, Max; Amberger, Christopher.
Afiliação
  • Behrens F; CIRI/Rheumatology University Hospital and Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, and Fraunhofer Cluster of Excellence for Immune-Mediated Diseases CIMD, Goethe University, Frankfurt, Germany. frank.be
  • Burmester GR; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Germany.
  • Hofmann MW; Chugai Pharma Germany GmbH, Rheumatology, Frankfurt am Main, Germany.
  • Aringer M; Division of Rheumatology, Department of Medicine III, TU Dresden, Germany.
  • Kellner H; Schwerpunktpraxis für Rheumatologie und Gastroenterologie, München, Germany.
  • Liebhaber A; Internistisch-Rheumatologische Arztpraxis, Halle, Germany.
  • Wassenberg S; Rheumazentrum Ratingen, Germany.
  • Peters MA; Roche Pharma AG, Grenzach-Wyhlen, Germany.
  • Zortel M; Roche Pharma AG, Grenzach-Wyhlen, Germany.
  • Amberger C; Rheumatologische Gemeinschaftspraxis, Bad Neuenahr, Germany.
Clin Exp Rheumatol ; 41(7): 1463-1472, 2023 Jul.
Article em En | MEDLINE | ID: mdl-36622132

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos Tipo de estudo: Diagnostic_studies / Observational_studies Limite: Adult / Humans / Middle aged Idioma: En Revista: Clin Exp Rheumatol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Antirreumáticos Tipo de estudo: Diagnostic_studies / Observational_studies Limite: Adult / Humans / Middle aged Idioma: En Revista: Clin Exp Rheumatol Ano de publicação: 2023 Tipo de documento: Article